Physician profile
Peter Russo
NPI 1720627037
$3,360.04
in general payments reported to CMS, 2019-2025
18 companies · $952 in 2025
The $952 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $238 · 2022: $206 · 2023: $697 · 2024: $1,267 · 2025: $952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,767 · Education: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,766.75 |
| Education | $149.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $901.28 | 2022-2025 | Sotyktu |
| Abbvie INC. | $769.18 | 2021-2025 | |
| Amgen INC. | $498.12 | 2021-2025 | Otezla, Otezla |
| Genzyme Corporation | $333.43 | 2021-2025 | |
| Janssen Biotech, INC. | $265.03 | 2023-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $94.68 | 2021-2025 | |
| Ucb, INC. | $89.09 | 2025 | Bimzelx |
| Lilly USA, LLC | $69.17 | 2023-2024 | Taltz, Olumiant |
| Leo Pharma INC. | $68.20 | 2023-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $54.46 | 2024-2025 | Dupixent |
| Pfizer INC. | $42.83 | 2023-2025 | |
| Medimetriks Pharmaceuticals, INC. | $31.24 | 2025 | Neo-Synalar |
| Springworks Therapeutics, INC. | $28.01 | 2025 | Gomekli |
| Lnhc, INC | $26.70 | 2025 | Zelsuvmi |
| Incyte Corporation | $26.04 | 2024 | Opzelura |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $23.92 | 2024 | Vtama |
| Sun Pharmaceutical Industries INC. | $21.13 | 2023 | Winlevi, Absorica Ld |
| Verrica Pharmaceuticals INC. | $17.53 | 2023 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.